The pharmaceutical company Double Bond Pharma announces that, after the recently completed set-off share issue in the company, Investentia now holds 14 percent of the shares and 13.3 percent of the votes.Before the issue, the holding amounted to 10.4 percent and 9.9 percent, respectively.This is stated in a major shareholding notification.